Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma

A prospective pilot study on radioimmunoscintigraphy with monoclonal antibody fragments against cutaneous melanoma (MoAb 225.28S) was carried out in 17 patients with a clinical diagnosis of choroidal melanoma. Monoclonal antibodies against melanoma-associated antigen were labeled with 740 mBq 99mTc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Graefe's archive for clinical and experimental ophthalmology 1989-01, Vol.227 (3), p.291-294
Hauptverfasser: SCHALING, D. F, VAN KROONENBURGH, M. J. P. G, BORSJE, R. A, CAMPUS, J. A. J, KAKEBEEKE-KEMME, H. M, OOSTERHUIS, J. A, PAUWELS, E. K. J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 294
container_issue 3
container_start_page 291
container_title Graefe's archive for clinical and experimental ophthalmology
container_volume 227
creator SCHALING, D. F
VAN KROONENBURGH, M. J. P. G
BORSJE, R. A
CAMPUS, J. A. J
KAKEBEEKE-KEMME, H. M
OOSTERHUIS, J. A
PAUWELS, E. K. J
description A prospective pilot study on radioimmunoscintigraphy with monoclonal antibody fragments against cutaneous melanoma (MoAb 225.28S) was carried out in 17 patients with a clinical diagnosis of choroidal melanoma. Monoclonal antibodies against melanoma-associated antigen were labeled with 740 mBq 99mTc and injected IV; images were made with a gamma camera at 6 h after injection. With a double-pinhole collimator, radioactivity was counted thrice in both eyes at 6 h after injection. In 6 of 16 patients (37.5%), the melanoma could be imaged with the gamma camera. With the double-pinhole collimator, a significantly higher activity was measured in the melanomatous eye in 13 of 16 patients (82.4%). In two patients a false negative result was obtained, and in one patient the difference between the left and right eye was not significant. Considering these results, radioimmunoscintigraphy may be valuable in ocular melanoma diagnostics, but the specificity of MoAb 225.28S needs to be assessed.
doi_str_mv 10.1007/BF02172765
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79051534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79051534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-65c24ceb4f06580ab66fe6143defb8d956e5ecf70e1b56632eb7c5ee86a59b7b3</originalsourceid><addsrcrecordid>eNpFkU1LAzEQhoMotVYv3oU9iAdhNR-bZHvUYlUoCKLQ25JkZ9vIJqmbXaT_3kirnubwPjPMPIPQOcE3BGN5ez_HlEgqBT9AY1IwnktMl4dojCUlecno8hidxPiBMU4hGaER5Rizko9R_apqG6xzgw_RWN_bVac26232Zft15qBVPjiVqxiDsaqHOnPBB9MGr9pMJVyHeps1nVo58H3MrM_MOnTB1in_bT9FR41qI5zt6wS9zx_eZk_54uXxeXa3yA0jpM8FN7QwoIsGC15ipYVoQKR7amh0WU-5AA6mkRiI5kIwCloaDlAKxadaajZBV7u5my58DhD7ytlooE1bQBhiJaeYE86KBF7vQNOFGDtoqk1nneq2FcHVj9LqX2mCL_ZTB-2g_kP3DlN-uc9VNKpNLryx8Q9LL6CCEvYN4QCAeg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79051534</pqid></control><display><type>article</type><title>Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>SCHALING, D. F ; VAN KROONENBURGH, M. J. P. G ; BORSJE, R. A ; CAMPUS, J. A. J ; KAKEBEEKE-KEMME, H. M ; OOSTERHUIS, J. A ; PAUWELS, E. K. J</creator><creatorcontrib>SCHALING, D. F ; VAN KROONENBURGH, M. J. P. G ; BORSJE, R. A ; CAMPUS, J. A. J ; KAKEBEEKE-KEMME, H. M ; OOSTERHUIS, J. A ; PAUWELS, E. K. J</creatorcontrib><description>A prospective pilot study on radioimmunoscintigraphy with monoclonal antibody fragments against cutaneous melanoma (MoAb 225.28S) was carried out in 17 patients with a clinical diagnosis of choroidal melanoma. Monoclonal antibodies against melanoma-associated antigen were labeled with 740 mBq 99mTc and injected IV; images were made with a gamma camera at 6 h after injection. With a double-pinhole collimator, radioactivity was counted thrice in both eyes at 6 h after injection. In 6 of 16 patients (37.5%), the melanoma could be imaged with the gamma camera. With the double-pinhole collimator, a significantly higher activity was measured in the melanomatous eye in 13 of 16 patients (82.4%). In two patients a false negative result was obtained, and in one patient the difference between the left and right eye was not significant. Considering these results, radioimmunoscintigraphy may be valuable in ocular melanoma diagnostics, but the specificity of MoAb 225.28S needs to be assessed.</description><identifier>ISSN: 0721-832X</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/BF02172765</identifier><identifier>PMID: 2500385</identifier><identifier>CODEN: GACODL</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Adult ; Aged ; Antibodies, Monoclonal ; Biological and medical sciences ; Choroid Neoplasms - diagnostic imaging ; Female ; Humans ; Hypersensitivity - immunology ; Injections, Intravenous ; Male ; Medical sciences ; Melanoma - diagnostic imaging ; Middle Aged ; Ophthalmology ; Pilot Projects ; Prospective Studies ; Radionuclide Imaging ; Skin Neoplasms - immunology ; Skin Tests ; Time Factors ; Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus ; Whole-Body Counting</subject><ispartof>Graefe's archive for clinical and experimental ophthalmology, 1989-01, Vol.227 (3), p.291-294</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-65c24ceb4f06580ab66fe6143defb8d956e5ecf70e1b56632eb7c5ee86a59b7b3</citedby><cites>FETCH-LOGICAL-c311t-65c24ceb4f06580ab66fe6143defb8d956e5ecf70e1b56632eb7c5ee86a59b7b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7212621$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2500385$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHALING, D. F</creatorcontrib><creatorcontrib>VAN KROONENBURGH, M. J. P. G</creatorcontrib><creatorcontrib>BORSJE, R. A</creatorcontrib><creatorcontrib>CAMPUS, J. A. J</creatorcontrib><creatorcontrib>KAKEBEEKE-KEMME, H. M</creatorcontrib><creatorcontrib>OOSTERHUIS, J. A</creatorcontrib><creatorcontrib>PAUWELS, E. K. J</creatorcontrib><title>Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma</title><title>Graefe's archive for clinical and experimental ophthalmology</title><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><description>A prospective pilot study on radioimmunoscintigraphy with monoclonal antibody fragments against cutaneous melanoma (MoAb 225.28S) was carried out in 17 patients with a clinical diagnosis of choroidal melanoma. Monoclonal antibodies against melanoma-associated antigen were labeled with 740 mBq 99mTc and injected IV; images were made with a gamma camera at 6 h after injection. With a double-pinhole collimator, radioactivity was counted thrice in both eyes at 6 h after injection. In 6 of 16 patients (37.5%), the melanoma could be imaged with the gamma camera. With the double-pinhole collimator, a significantly higher activity was measured in the melanomatous eye in 13 of 16 patients (82.4%). In two patients a false negative result was obtained, and in one patient the difference between the left and right eye was not significant. Considering these results, radioimmunoscintigraphy may be valuable in ocular melanoma diagnostics, but the specificity of MoAb 225.28S needs to be assessed.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Monoclonal</subject><subject>Biological and medical sciences</subject><subject>Choroid Neoplasms - diagnostic imaging</subject><subject>Female</subject><subject>Humans</subject><subject>Hypersensitivity - immunology</subject><subject>Injections, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Melanoma - diagnostic imaging</subject><subject>Middle Aged</subject><subject>Ophthalmology</subject><subject>Pilot Projects</subject><subject>Prospective Studies</subject><subject>Radionuclide Imaging</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Tests</subject><subject>Time Factors</subject><subject>Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus</subject><subject>Whole-Body Counting</subject><issn>0721-832X</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkU1LAzEQhoMotVYv3oU9iAdhNR-bZHvUYlUoCKLQ25JkZ9vIJqmbXaT_3kirnubwPjPMPIPQOcE3BGN5ez_HlEgqBT9AY1IwnktMl4dojCUlecno8hidxPiBMU4hGaER5Rizko9R_apqG6xzgw_RWN_bVac26232Zft15qBVPjiVqxiDsaqHOnPBB9MGr9pMJVyHeps1nVo58H3MrM_MOnTB1in_bT9FR41qI5zt6wS9zx_eZk_54uXxeXa3yA0jpM8FN7QwoIsGC15ipYVoQKR7amh0WU-5AA6mkRiI5kIwCloaDlAKxadaajZBV7u5my58DhD7ytlooE1bQBhiJaeYE86KBF7vQNOFGDtoqk1nneq2FcHVj9LqX2mCL_ZTB-2g_kP3DlN-uc9VNKpNLryx8Q9LL6CCEvYN4QCAeg</recordid><startdate>19890101</startdate><enddate>19890101</enddate><creator>SCHALING, D. F</creator><creator>VAN KROONENBURGH, M. J. P. G</creator><creator>BORSJE, R. A</creator><creator>CAMPUS, J. A. J</creator><creator>KAKEBEEKE-KEMME, H. M</creator><creator>OOSTERHUIS, J. A</creator><creator>PAUWELS, E. K. J</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19890101</creationdate><title>Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma</title><author>SCHALING, D. F ; VAN KROONENBURGH, M. J. P. G ; BORSJE, R. A ; CAMPUS, J. A. J ; KAKEBEEKE-KEMME, H. M ; OOSTERHUIS, J. A ; PAUWELS, E. K. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-65c24ceb4f06580ab66fe6143defb8d956e5ecf70e1b56632eb7c5ee86a59b7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Monoclonal</topic><topic>Biological and medical sciences</topic><topic>Choroid Neoplasms - diagnostic imaging</topic><topic>Female</topic><topic>Humans</topic><topic>Hypersensitivity - immunology</topic><topic>Injections, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Melanoma - diagnostic imaging</topic><topic>Middle Aged</topic><topic>Ophthalmology</topic><topic>Pilot Projects</topic><topic>Prospective Studies</topic><topic>Radionuclide Imaging</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Tests</topic><topic>Time Factors</topic><topic>Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus</topic><topic>Whole-Body Counting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHALING, D. F</creatorcontrib><creatorcontrib>VAN KROONENBURGH, M. J. P. G</creatorcontrib><creatorcontrib>BORSJE, R. A</creatorcontrib><creatorcontrib>CAMPUS, J. A. J</creatorcontrib><creatorcontrib>KAKEBEEKE-KEMME, H. M</creatorcontrib><creatorcontrib>OOSTERHUIS, J. A</creatorcontrib><creatorcontrib>PAUWELS, E. K. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHALING, D. F</au><au>VAN KROONENBURGH, M. J. P. G</au><au>BORSJE, R. A</au><au>CAMPUS, J. A. J</au><au>KAKEBEEKE-KEMME, H. M</au><au>OOSTERHUIS, J. A</au><au>PAUWELS, E. K. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma</atitle><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><date>1989-01-01</date><risdate>1989</risdate><volume>227</volume><issue>3</issue><spage>291</spage><epage>294</epage><pages>291-294</pages><issn>0721-832X</issn><eissn>1435-702X</eissn><coden>GACODL</coden><abstract>A prospective pilot study on radioimmunoscintigraphy with monoclonal antibody fragments against cutaneous melanoma (MoAb 225.28S) was carried out in 17 patients with a clinical diagnosis of choroidal melanoma. Monoclonal antibodies against melanoma-associated antigen were labeled with 740 mBq 99mTc and injected IV; images were made with a gamma camera at 6 h after injection. With a double-pinhole collimator, radioactivity was counted thrice in both eyes at 6 h after injection. In 6 of 16 patients (37.5%), the melanoma could be imaged with the gamma camera. With the double-pinhole collimator, a significantly higher activity was measured in the melanomatous eye in 13 of 16 patients (82.4%). In two patients a false negative result was obtained, and in one patient the difference between the left and right eye was not significant. Considering these results, radioimmunoscintigraphy may be valuable in ocular melanoma diagnostics, but the specificity of MoAb 225.28S needs to be assessed.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>2500385</pmid><doi>10.1007/BF02172765</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0721-832X
ispartof Graefe's archive for clinical and experimental ophthalmology, 1989-01, Vol.227 (3), p.291-294
issn 0721-832X
1435-702X
language eng
recordid cdi_proquest_miscellaneous_79051534
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adult
Aged
Antibodies, Monoclonal
Biological and medical sciences
Choroid Neoplasms - diagnostic imaging
Female
Humans
Hypersensitivity - immunology
Injections, Intravenous
Male
Medical sciences
Melanoma - diagnostic imaging
Middle Aged
Ophthalmology
Pilot Projects
Prospective Studies
Radionuclide Imaging
Skin Neoplasms - immunology
Skin Tests
Time Factors
Tumors and pseudotumors of the eye, orbit, eyelid, lacrimal apparatus
Whole-Body Counting
title Radioimmunoscintigraphy with melanoma-associated monoclonal antibody fragments in choroidal melanoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T14%3A27%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Radioimmunoscintigraphy%20with%20melanoma-associated%20monoclonal%20antibody%20fragments%20in%20choroidal%20melanoma&rft.jtitle=Graefe's%20archive%20for%20clinical%20and%20experimental%20ophthalmology&rft.au=SCHALING,%20D.%20F&rft.date=1989-01-01&rft.volume=227&rft.issue=3&rft.spage=291&rft.epage=294&rft.pages=291-294&rft.issn=0721-832X&rft.eissn=1435-702X&rft.coden=GACODL&rft_id=info:doi/10.1007/BF02172765&rft_dat=%3Cproquest_cross%3E79051534%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79051534&rft_id=info:pmid/2500385&rfr_iscdi=true